---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010875"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T12:19:44.511169+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve Series B conversion price cut to $1.50 and 2022 equity plan expansion

## Summary
- Series B Preferred conversion price reduced to $1.50 (from $2.25); floor price removed; dividend rights eliminated.
- 2022 Equity Incentive Plan amended: share reserve 10M shares, evergreen up to 2M shares/yr, max 26M shares.
- Stockholders approved issuance of Mango & Peaches subsidiary shares to CEO Jacob Cohen under Nasdaq Rule 5635.
- All four proposals approved at March 17, 2025 special meeting; Proposal 1 received 98.8% common and 100% Series B votes.
- Designation Amendment filed with Texas Secretary of State on March 17, 2025, effective upon stockholder approval.

## SEC filing metadata
- accession: 0001493152-25-010875
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 5.03, 3.03, 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225010875/0001493152-25-010875-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225010875/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010875
- JSON: https://secwatch.observer/filing/0001493152-25-010875.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010875.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.